SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001628280-19-013991
Filing Date
2019-11-12
Accepted
2019-11-12 16:28:01
Documents
54
Period of Report
2019-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q rgls20190930-10q.htm 10-Q 1252782
2 EXHIBIT 10.6 ex-106x20190930.htm EX-10.6 16316
3 EXHIBIT 10.7 ex-107x20190930.htm EX-10.7 100508
4 EXHIBIT 31.1 ex-311x20190930.htm EX-31.1 12040
5 EXHIBIT 31.2 ex-312x20190930.htm EX-31.2 12017
6 EXHIBIT 32.1 ex-321x20190930.htm EX-32.1 11811
  Complete submission text file 0001628280-19-013991.txt   5612468

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT rgls-20190930.xml EX-101.INS 963281
8 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT rgls-20190930.xsd EX-101.SCH 41772
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT rgls-20190930_cal.xml EX-101.CAL 70190
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT rgls-20190930_def.xml EX-101.DEF 205665
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT rgls-20190930_lab.xml EX-101.LAB 613974
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT rgls-20190930_pre.xml EX-101.PRE 331963
Mailing Address 10628 SCIENCE CENTER DRIVE SUITE 225 SAN DIEGO CA 92121
Business Address 10628 SCIENCE CENTER DRIVE SUITE 225 SAN DIEGO CA 92121 858-202-6300
Regulus Therapeutics Inc. (Filer) CIK: 0001505512 (see all company filings)

IRS No.: 264738379 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35670 | Film No.: 191209941
SIC: 2834 Pharmaceutical Preparations